This brand name is authorized in Nigeria. It is also authorized in Ecuador, Malta.
The drug ENTEROGERMINA contains one active pharmaceutical ingredient (API):
1
|
UNII
KQ2N4RPK58 - BACILLUS CLAUSII
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-9852 | Suspension | Enterogermina Oral Suspension SUSP 2 BillionSpores/5 mL 5 mL x 20’s (in mini bottles) | Oral suspension in 5-mL ready-to-drink mini bottles | 25/02/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A07FA01 | Lactic acid producing organisms | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 1035-MEE-0615, 3134-MEE-1217, 6367-MEE-0621, H7301013 |
| MT | Medicines Authority | AA1470/01201, AA1470/01202, AA1470/01203 |
| NG | Registered Drug Product Database | A4-9852 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.